CryoPortCYRX
About: CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Employees: 1,186
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
3,011% more call options, than puts
Call options by funds: $2.21M | Put options by funds: $71K
48% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 21
33% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 45
7% more funds holding
Funds holding: 150 [Q3] → 160 (+10) [Q4]
1.83% more ownership
Funds ownership: 93.93% [Q3] → 95.76% (+1.83%) [Q4]
2% less capital invested
Capital invested by funds: $376M [Q3] → $368M (-$7.84M) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Needham David Saxon 31% 1-year accuracy 20 / 65 met price target | 87%upside $11 | Buy Reiterated | 16 Apr 2025 |
Guggenheim Subbu Nambi 19% 1-year accuracy 4 / 21 met price target | 70%upside $10 | Buy Reiterated | 16 Apr 2025 |
Roth MKM Richard Baldry 22% 1-year accuracy 4 / 18 met price target | 155%upside $15 | Buy Reiterated | 1 Apr 2025 |
UBS John Sourbeer 0% 1-year accuracy 0 / 3 met price target | 87%upside $11 | Buy Maintained | 1 Apr 2025 |
Financial journalist opinion
Based on 4 articles about CYRX published over the past 30 days









